Vaccine Press Releases

DPI Research has recently updated its massive report catalogue by adding a fresh study titled "Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential".

Global Vaccine for Non-infectious Meningitis Market Insights, Forecast to 2025

Global Animal Vaccine Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Biosceptre has initiated its Phase I clinical trial of the peptide vaccine BIL06v, with the first patient treated at the initial trial site on 16th of August 2018.

Gold law Firm, LLC., recently filed a vaccine petition for a Massachusetts woman who had a severe vaccine injury reaction to the Flu Vaccine resulting in SIRVA, Shoulder Injury Related to Vaccine Administration.

The proposed Phase I clinical trial for BIL06v (anti-cancer vaccine) was granted conditional approval by the Bellberry Ethics committee on 21st February 2018.

DPI Research adds " Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2024 " to its offering

Biosceptre has received over £8M into its series A raise which will be used to resource the next stage of the companies' development; progression into the clinic of Biosceptre's first systemic products against novel oncology target nfP2X7.